Barely Significant
← all excerpts

TP53 Functional-Domain-Specific Mutations Define Distinct Clinical Outcomes in EGFR-Mutant Non-Small Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors.

J Clin Med · 2026 · PMC12941704 · PMID 41753239

Europe PMCDOI
1
hedged sentence
0.0230
closest p · 0.5× alpha
0.0230
boldest claim

The sentences

a significant trendp = 0.023actually significant
When TP53 status was modeled as an ordinal variable, a significant trend toward worse PFS was observed (HR per step 1.28, 95% CI 1.03–1.59; p = 0.023).

also in 6,184 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.